Karl Elmqvist
Director/Board Member at AnaCardio AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Bengt Eldered | M | 64 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | - |
| Lars Lund | M | - |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| Karin Hehenberger | M | 52 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| Alice Gast | M | 65 |
Imperial College London
| 10 years |
| Carl-Johan Spak | M | 68 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | - |
| Anders Olof Adolf Ekblom | M | 70 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | - |
| Mark Royston Quick | M | 58 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 2 years |
| Fredrik Lehmann | M | 48 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| John Öhd | M | 53 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| Ted Ingemar Jakob Fjällman | M | 46 |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 5 years |
| Johan Dighed | M | 51 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| Patrik Strömberg | M | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | 3 years |
| Charlotta Poehler | F | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
| Carlos von Bonhorst | M | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 2 years |
| Cecilia Schéele | F | - |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael Kyriakides | M | - |
Imperial College London
| 7 years |
| Aiste Satkute | F | - |
Imperial College London
| 1 years |
| Adam Karlsson | M | - |
Imperial College London
| 6 years |
| Clea Kolster | F | - |
Imperial College London
| 8 years |
| Joshua Lowe | M | - |
Imperial College London
| 4 years |
| Ruchir Saraswat | M | - |
Imperial College London
| 10 years |
| Claire Vassie | F | - |
Imperial College London
| 6 years |
| Madeleine Jenkins | F | - |
Imperial College London
| 4 years |
| Matt Cobbold | M | - |
Imperial College London
| 4 years |
| Philippa Christoforou | M | - |
Imperial College London
| 3 years |
| Pahrada Sapprasert | F | - |
Imperial College London
| 1 years |
| Chris Herson | M | - |
Imperial College London
| 1 years |
| Magali Christensen | F | - |
Imperial College London
| 4 years |
| Benedicte Lorentze Aune | M | - |
Imperial College Business School
| 1 years |
| Emmanuel Limal | M | - |
Imperial College London
| 3 years |
| Reena Sharma | F | - |
Imperial College London
| 1 years |
| Alexandra Radu | F | - |
Imperial College London
| 1 years |
| Leigh Brody | M | - |
Imperial College London
| 4 years |
| Jared Ruddy | M | - |
Imperial College Business School
| 2 years |
| Dylan Rebois | M | - |
Imperial College London
| 1 years |
| Zixuan Wang | F | - |
Imperial College London
| 4 years |
| Tom Mulqueen | M | - |
Imperial College London
| 4 years |
| Colin B. Besant | M | 87 |
Imperial College London
| - |
| Pooja Sikka | F | - |
Imperial College London
| 1 years |
| Yuan Kui Yang | M | 36 |
Imperial College London
| 4 years |
| Ho Law Wai | M | - |
Imperial College London
| 3 years |
| Daryl Ng | M | - |
Imperial College London
| 3 years |
| Fang Xin Li | M | 32 |
Imperial College London
| 4 years |
| Michael Devereux | M | - |
Imperial College London
| 1 years |
| Anna Shevkunova | F | - |
Imperial College Business School
| 1 years |
| Folashade Oyewole | F | - |
Imperial College Business School
| 4 years |
| Noah Geeves | M | - |
Imperial College London
| 4 years |
| Daniel Ushakov | M | - |
Imperial College London
| 4 years |
| Angelo Magli | M | - |
Imperial College London
| 4 years |
| Jamie Harris | M | - |
Imperial College Business School
| 1 years |
| Raj Mukherji | M | - |
Imperial College London
| 4 years |
| Christian Theisen | M | - |
Imperial College Business School
| 1 years |
| Woody Polglase | M | - |
Imperial College London
| 4 years |
| Martin Azzinnaro | M | - |
Imperial College London
| 4 years |
| Covadonga García-Valdés | F | - |
Imperial College London
| - |
| Qian Lu | F | - |
Imperial College London
| 1 years |
| Deji Sasegbon | M | - |
Imperial College London
| 5 years |
| Anishaa Pattani | F | - |
Imperial College London
| 4 years |
| Tania J Minato | F | - |
Imperial College London
| 1 years |
| Javier Echavarri Fernandez | M | - |
Imperial College London
| 4 years |
| Chenshihui Lin | F | - |
Imperial College London
| 4 years |
| Lucas Vuurmans | M | - |
Imperial College London
| 1 years |
| Letizia Bellucci | F | 33 |
Imperial College London
| 3 years |
| Yu Cheng Niu | M | - |
Imperial College London
| 1 years |
| Ben Pfannes-Varrow | M | - |
Imperial College Business School
| 1 years |
| Leo Castellanos | M | - |
Imperial College London
| 1 years |
| Tariq bin Hendi | M | - |
Imperial College London
| 7 years |
| Mansoor Hamayun | M | 36 |
Imperial College London
| - |
| Marco Londei | M | 68 |
Imperial College London
| 14 years |
| Jonathan Leslie Tobin | M | 42 |
Imperial College London
| 3 years |
| Giuliano Sison | M | - |
Imperial College London
| 5 years |
| Niall Tomlinson | M | - |
Imperial College London
| 1 years |
| Kieran McGrath | M | - |
Imperial College London
| 1 years |
| Robert Keith O'Nions | M | - |
Imperial College London
| 6 years |
| Giorgio Broetz | M | - |
Imperial College London
| 1 years |
| Michael E. Moore | M | - |
Imperial College London
| 12 years |
| David Begg | M | 74 |
Imperial College London
| 9 years |
| Julia Higgins | M | 82 |
Imperial College London
| 23 years |
| Florian Kunkel | M | - |
Imperial College London
| 1 years |
| Yanmo Omorogbe | F | - |
Imperial College London
| 4 years |
| Kunal Atul Bora | M | 27 |
Imperial College London
| 2 years |
| Philip Gunnarsson | M | - |
Imperial College London
| 1 years |
| David Christopher Allen | M | 70 |
Imperial College London
| - |
| Safi Keshvargar | M | - |
Imperial College Business School
| 1 years |
| Alexander Babulevich | M | - |
Imperial College London
| 4 years |
| Jakub Skrzynecki | M | - |
Imperial College London
| 1 years |
| Anta Gkelou | M | 38 |
Imperial College London
| 4 years |
| Deepka Rana | F | - |
Imperial College London
| 3 years |
| Scarlett Benson | F | - |
Imperial College London
| 1 years |
| Roger Liew | M | - |
Imperial College London
| 4 years |
| Coral Uguina Marquez | F | - |
Imperial College London
| 4 years |
| Farhad Abbasov | M | - |
Imperial College Business School
| 1 years |
| Kayan Kanga | M | - |
Imperial College London
| 4 years |
| Zhui Pei Yeo | M | - |
Imperial College London
| 4 years |
| Pavlos Pavlakis | M | - |
Imperial College London
| 1 years |
| Satnam Reehal | M | - |
Imperial College London
| 4 years |
| Miguel Pais e Sousa | M | - |
Imperial College Business School
| 1 years |
| Zue Leong | F | - |
Imperial College London
| 4 years |
| Thanasi Skafidas | M | 35 |
Imperial College London
| 1 years |
| Andrea Pelliccia | M | - |
Imperial College London
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 86 | 86.00% |
| Sweden | 14 | 14.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karl Elmqvist
- Personal Network
